Consumer Views about Codeine Rescheduling

The Australian Pain Management Association has been asked to give consumer feedback on consumer views about over-the-counter codeine combination products becoming only available by prescription on 1 February 2018. We are interested in your understanding and attitudes on this issue so that we can represent your views as accurately as possible.

* 1. Gender:

* 2. State:

* 3. Are you aware that from 1 February 2018, over-the-counter (OTC) codeine combination products eg Panadeine or Nurofen Plus will only be available on prescription?

* 4. Do you want OTC codeine combination products available without a prescription?

* 5. Which of the following conditions do you use OTC codeine combination products to treat? Tick as many as preferred.

* 6. Are you aware that OTC codeine combination products have been associated with significant harms, eg. gastrointestinal bleeding, liver failure and even death?

* 7. Which type/s of of pain have you used OTC codeine combination products for?

* 8. Will you be disadvantaged when OTC codeine combination products are only available by prescription?

* 9. What is the reason/s you could be disadvantaged by having to see a doctor to get a prescription? Tick as many as you prefer.

* 10. Do you want APMA to advocate for OTC codeine combination products to be available without a prescription?

T